Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior — TAILOR  

Insomnia Clinical Trial

Official title: Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior

Status Recruiting

Clinical Trial Summary

This study will test the effectiveness of a sleep-related primary suicide prevention program entitled TAILOR (Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior), which includes specific behavior-change strategies for adolescents at risk of suicidal behavior who suffer from difficulties falling asleep, staying asleep, and/or insufficient sleep.

Clinical Trial Description

This study will test the effectiveness of TAILOR, a multifaceted intervention designed to reduce sleep problems and markers of suicide risk in adolescents. The TAILOR intervention will incorporate 3 different empirically-based behavioral-change approaches for addressing adult sleep and/or adolescent non-sleep behaviors, including Cognitive Behavioral Therapy, Motivational Interviewing, and voice- or video call-based assistance with adolescents with recent suicidal ideation and either no history of suicide attempt or suicide attempt at least 3 months ago. Hypotheses: 1. Adolescents receiving the TAILOR intervention will have better sleep according to both youth and parent/Legal Guardian (P/LG) reports relative to adolescents in the Enhanced Usual Care (EUC) condition at 2 and 4 months. 2. The TAILOR intervention will result in significant reductions in suicidal ideation relative to the EUC condition at 4 months. Exploratory secondary aims: 1. Determine if (a) the response to the TAILOR intervention varies by gender, race/ ethnicity, medication status, or type of insomnia (e.g., difficulties falling versus staying asleep) and (b) TAILOR impacts other health risk behavior domains besides sleep and suicidal ideation. 2. Assess if improved sleep at 2 months mediates the relationship between receiving the TAILOR intervention and lower suicidal ideation at 4 months. 3. Test whether TAILOR is superior to EUC in reducing suicide attempts at 4 months. One hundred ninety youths aged 11 years, 0 months, to 18 years, 11 months, inclusive at time of consent, with sleep problems (within the past month) and suicidal ideation (within the past 90 days) will be randomized to either TAILOR (n=95) or to EUC (n=95). Suicidal ideation refers to thoughts about killing oneself, as well as contemplation of the when, where, and how of suicide. As such, suicidal ideation is considered proximal on a spectrum of severity for suicidal behaviors ranging from ideation to threats, to attempts, and to suicide. A major goal of TAILOR is thus to eliminate or at the very least minimize suicidal ideation. Study outcomes will be assessed at 2- and 4- months post-randomization by an independent evaluator blind to participant status. Primary study outcomes will be sleep problems and suicidal ideation, major modifiable markers of suicide risk. All randomized participants will be followed for the duration of the study regardless of treatment compliance or clinical outcomes according to the protocol assessment, and main study analyses will follow an intent-to-treat (ITT) approach. ;

Related Conditions & MeSH terms

• Insomnia
• Sleep Initiation and Maintenance Disorders
• Suicidal Ideation
• Suicide
• Suicide, Attempted

• NCT number: NCT05390918
• Study type: Interventional
• Source: Nationwide Children's Hospital
• Contact: Elizabeth Cannon, MA, MS
• Phone: 614-355-0578
• Email: elizabeth.cannon@nationwidechildrens.org
• Status: Recruiting
• Phase: N/A
• Start date: October 20, 2022
• Completion date: July 2026